SCALONE, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 392
AS - Asia 70
EU - Europa 63
Totale 525
Nazione #
US - Stati Uniti d'America 391
CN - Cina 36
UA - Ucraina 20
SG - Singapore 18
DE - Germania 16
TR - Turchia 13
GB - Regno Unito 8
IT - Italia 8
FI - Finlandia 5
SE - Svezia 4
IN - India 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CA - Canada 1
FR - Francia 1
Totale 525
Città #
Fairfield 59
Woodbridge 56
Chandler 32
Ann Arbor 31
Ashburn 31
Jacksonville 26
Seattle 23
Wilmington 19
Santa Clara 18
Cambridge 17
Houston 17
Singapore 17
Beijing 13
Izmir 7
Boardman 5
Jiaxing 5
Princeton 5
Milan 4
Nanchang 4
Nanjing 4
Bremen 3
Hebei 3
San Diego 3
Auburn Hills 2
Changsha 2
Des Moines 2
Ferrara 2
London 2
Norwalk 2
Redwood City 2
Shanghai 2
Dearborn 1
Dubai 1
Frankfurt am Main 1
Hyderabad 1
Indiana 1
Islington 1
Kumar 1
Los Angeles 1
Mountain View 1
Ningbo 1
Redmond 1
Shenyang 1
Sofia 1
Stockholm 1
Toronto 1
Washington 1
Totale 434
Nome #
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 126
Frequency of “Pocket” Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study) 123
A migrant left ventricular lead 114
Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward 105
STABLE CORONONARY ARTERY DISEASE 136 QUESTION AND ANSWERS 64
Totale 532
Categoria #
all - tutte 2.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 0 18 10 12 12 13 9 2
2020/202162 6 6 1 10 2 5 1 16 0 6 6 3
2021/202243 0 4 5 1 1 3 3 2 3 5 6 10
2022/202368 6 2 4 5 19 8 5 7 5 0 4 3
2023/202422 5 0 2 0 2 7 0 1 0 0 0 5
2024/202544 2 1 10 3 19 9 0 0 0 0 0 0
Totale 532